All community pharmacist articles
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19
-
Information
COVID-19 hub for community pharmacy
The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of professional bodies.
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
NICE CKS on infective conjunctivitis
A summary of guidance to assist community pharmacy teams with the diagnosis and management of infective conjunctivitis
-
PHE/DH/DWP guideline
PHE oral health in children guidance
A summary of guidance to assist community pharmacy teams to promote the benefits of good oral health for children
-
NICE guideline
NICE CKS on chickenpox
Management of chickenpox in healthy children and adults, during pregnancy and breastfeeding, and in people who are immunocompromised
-
NICE guideline
NICE CKS on common cold
A useful summary for community pharmacists covering diagnosis, management, and prescribing information in adults, children, and young people
-
NICE guideline
NICE CKS on halitosis
A summary of guidance to assist community pharmacy teams on the diagnosis and management of halitosis (bad breath)
-
PHE/DH/DWP guideline
PHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
NICE guideline
NICE CKS on gingivitis and periodontitis
A summary of guidance to assist community pharmacy teams on the diagnosis and management of gingivitis and periodontitis
-
Independent professional body guideline
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
-
NICE guideline
NICE CKS on rosacea
A summary of guidance to assist healthcare professionals on the diagnosis and management of rosacea
-
PHE/DH/DWP guideline
PHE management of patient/staff exposure to COVID-19
This summary provides guidance on the management of staff and patients according to exposures, symptoms, and test results
-
PHE/DH/DWP guideline
NHS England COVID-19 vaccination SOP
This standard operating procedure (SOP) summary describes the operating model and design requirements for safe delivery of COVID-19 vaccines in the community
-
News
COVID-19 vaccinations to be delivered by high street pharmacies from today
As the NHS accelerates its largest vaccination programme to date, high street pharmacies have begun delivering protective COVID-19 vaccinations
-
NICE guideline
NICE CKS on constipation
Areas covered in the summary include: advice for those with the condition, management (short-duration and chronic), secondary causes of the condition, and prescribing information
-
Information
OTC quick reference guide
A quick reference tool summarising CCG guidance on conditions for which over-the-counter items should not routinely be prescribed in primary care.
-
NICE guideline
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
-
PHE/DH/DWP guideline
PHE influenza immunisation 2020/21 guideline
This Guidelines summary covers key information on expansion of the 2020-21 flu immunisation programme.
-
Independent professional body guideline
FSRH guideline on contraception for women over 40
A summary of guidance for healthcare practitioners working in sexual and reproductive healthcare regarding contraception in women over 40